Lab Notes: Fox Chase Cancer Center enters Pfizer genomic disparities collaboration; Avstera Therapeutics raises $4.55M


A Philadelphia biotech startup focused on solid tumor cancers raised $4.55 million in seed funding.

Previous Centene to sell specialty benefit management business Magellan Specialty Health in latest divesture
Next Here's how many OhioHealth IT workers left for Accenture, elsewhere ahead of layoffs